Company: HCTI
Filing Date: 2025-05-15
Form Type: 424B4
Source: 0001213900-25-044095
Chunk: 24

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-15
Form: 424B4
Chunk 24
---
 common stock
that may be obtained by exercising the Series B Warrant at an exercise price of $0.84; however if the holder elects the zero exercise
price option, the number of shares of common stock could increase to up to 30 shares of common stock underlying each Series B Warrant
if the exercise price decreases to and equals the Floor Price at the time of such election. As such, holders of the Series B Warrants
may elect to be issued up to 1,085,714,550 shares of common stock upon the exercise of the Series B Warrants assuming the Floor Price.
For a description of the risks involved with exercise of the Series B Warrants, see “Risk Factors—Risks Related to this Offering.”

Pursuant to the Purchase Agreement,
the Company has agreed that until ninety (90) days after the effective date of the Registration Statement, neither the Company nor any
of its subsidiaries shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of
Common Stock or Common Stock equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case
other than as contemplated pursuant to the Registration Rights Agreement (as defined below) or, solely with respect to securities issued
pursuant to any share or option plan duly adopted for such purpose by the Company’s board of directors or a committee of non-employee
directors established for such purpose for services rendered to the Company, on Form S-8. However, the Company shall be permitted to issue
up to 500,000 options to purchase shares pursuant to the Company’s equity incentive plan, subject to certain exceptions set forth
in the Purchase Agreement.

Pursuant to the Purchase Agreement,
the Company has also agreed that until one hundred and eighty (180) days after the effective date of the registration statement, the Company
and any of its subsidiaries shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or
any of its subsidiaries of shares of Common Stock or Common Stock equivalents (or a combination of units thereof) involving a Variable
Rate Transaction, subject to certain exception set forth in the Purchase Agreement.

“Variable Rate Transaction”
means a transaction in which the Company (i) issues or sells any shares of Common Stock or Common Stock equivalents either (A) at a conversion
price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations